|
339 Doubts cast over
benefit of flu jabs for elderly people As
the annual influenza immunisation campaigns kick off in Britain next
week, evidence for the benefits of vaccinating elderly people against
flu is questioned in a review article published online
PJ 2007;279:339
Full Text
339 Brown and Johnson highlight pharmacy
roles Pharmacies are to have an expanded
role in providing medical services and tackling health inequalities,
Gordon Brown and Alan Johnson told the Labour Party conference in Bournemouth
this week
PJ 2007;279:339
Full Text
339 Conference event focuses on interprofessional
working Socialist think-tank the Fabian Society organised a roundtable event during the Labour Party conference in Bournemouth entitled: “Bringing care closer to patients; but can pharmacists, GPs and commissioners work together to achieve it?”
PJ 2007;279:339
Full Text
340 Independent prescriber
starts clinic in own pharmacy Kamal Mahasuria,
director of Altwood Pharmacy in Maidenhead, Berkshire, became one of the first
pharmacist independent prescribers to write an NHS prescription in his community
pharmacy this week. Mr Mahasuria is running an asthma clinic from his pharmacy
in partnership with a local GP practice
PJ 2007;279:340
Full Text
340 Integrated electronic systems improve safety Patient
safety in hospitals is increased by the use of integrated electronic medicines
management systems, new research shows. Combining electronic prescribing with
automated dispensing, bar-coded administration and an electronic record of medication
administration reduces prescribing and administration errors by almost half,
according to the study from a London teaching hospital
PJ 2007;279:340
Full Text
340 Half of new PECs have kept pharmacists as
members Just over half of new professional executive
committees (PECs) in England currently include pharmacists, according to a survey
recently conducted by the Pharmaceutical Service Negotiating Committee
PJ 2007;279:340
Full Text
340 Fifteen per cent of patients in Scotland
have registered with minor ailment service One
in seven patients in Scotland is now registered with the community pharmacy minor
ailment service
PJ 2007;279:340
Full Text
341 Pharmacy law group: conserve
part-time workforce Pharmacists’ fees need to be structured in a way that is more responsive to the needs of the workforce and a breakdown of costs is needed to justify increases, the Pharmacy Law and Ethics Association believes. Justification is also needed for increases in premises fees, the Pharmaceutical Services Negotiating Committee says
PJ 2007;279:341
Full Text
341 Pension agreement reached for NHS staff New
pension arrangements for NHS staff in England and Wales will start in April 2008
following acceptance of the final agreement for changes to the pension scheme
by health minister Ben Bradshaw last week
PJ 2007;279:341
Full Text
341 Royal College of Art and Lloyds explore
pharmacy design Lloydspharmacy has teamed up with the Royal College of Art to come up with a range of “design proposals” on how pharmacies could look in the future
PJ 2007;279:341
Full Text
341 Welsh medicines information to trial out-of-hours
service Access to medicines information will be
available in the evenings and at weekends for health care professionals in Wales
as part of a trial being run by the Welsh medicines information service
PJ 2007;279:341
Full Text
341 Clarke inquiry clerk John
Thompson, non-executive director of Richmond and Twickenham Primary Care Trust,
has been appointed clerk to the independent inquiry into a professional body
for pharmacy being led by Nigel Clarke
PJ 2007;279:341
Full Text
341 Practice-based commissioning Community
pharmacy is again the subject of an NHS Primary Care Contracting bulletin
PJ 2007;279:341
Full Text
342 Detemir presents mixed
blessing for type 2 diabetes Basal insulin detemir
is less effective at reducing the HbA1c of patients with poorly controlled type
2 diabetes than twice-daily biphasic or thrice-daily meal-time (prandial) insulin
regimens but it is associated with less weight gain and fewer hypoglycaemic episodes,
according to a study
PJ 2007;279:342
Full Text
342 Global view on education begins to take
shape Progress towards a global view on pharmacy
education has been made at a roundtable discussion, which took place early this
month at the International Pharmaceutical Federation (FIP) congress in Beijing
PJ 2007;279:342
Full Text
342 PSNC to seek modest increase in low-volume
threshold More low-dispensing-volume contractors
could be assisted by an increase in the low-dispensing threshold below the increase
in prescription volume, the Pharmaceutical Services Negotiating Committee says
PJ 2007;279:342
Full Text
342 Spotlight on paediatric medicines Paediatric
medicines safety is the focus of a new World Health Organization report
PJ 2007;279:342
Full Text
342 Allergy report Adequate
allergy training for pharmacists should be provided to ensure they offer high-quality
advice to allergy sufferers, the House of Lords Science and Technology Committee
has concluded
PJ 2007;279:342
Full Text
342 Online pharmacy from Rowlands Rowlands
has launched an online pharmacy, www.rowlandspharmacy.co.uk
PJ 2007;279:342
Full Text
343 New data support HPV vaccination
programme Up to 70 per cent of cervical cancer cases and 95 per cent of genital wart cases could be prevented by the introduction of a human papillomavirus (HPV) vaccination programme in the UK, according to modelling research carried out by the Health Protection Agency. The finding comes as the second HPV vaccine — Cervarix — is launched in the UK
PJ 2007;279:343
Full Text
343 Five-year follow-up data confirm efficacy
of oral chemotherapy in early bowel cancer Oral
chemotherapy with capecitabine (Xeloda) achieves equivalent survival to 5-fluorouracil/folinic
acid (5-FU/FA) administered as an intravenous bolus in early bowel cancer, according
to five-year follow-up results from the X-ACT trial, reported this week at the
European Cancer Conference in Barcelona. The data suggest a trend to better survival
with capecitabine
PJ 2007;279:343
Full Text
343 End to Viracept suspension authorised by
EMEA An end to the suspension of the marketing
authorisation for Viracept (nelfinavir) and re-introduction of the drug to the
EU market has been recommended by the European Medicines Agency (EMEA). Marketing
authorisation for Viracept was suspended earlier this year following contamination
of several batches with a genotoxic substance
PJ 2007;279:343
Full Text |
The
Pharmaceutical Journal